Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
We showed previously that pulmonary function and arterial oxygen saturation in NY1DD mice with sickle cell disease (SCD) are improved by depletion of invariant natural killer T (iNKT) cells or blockade of their activation. Here we demonstrate that SCD causes a 9- and 6-fold induction of adenosine A2A receptor (A2AR) mRNA in mouse pulmonary iNKT and natural killer (NK) cells, respectively. Treating SCD mice with the A2AR agonist ATL146e produced a dose-dependent reversal of pulmonary dysfunction with maximal efficacy at 10 ng/kg/minute that peaked within 3 days and persisted throughout 7 days of continuous infusion. Crossing NY1DD mice with Rag1−/− mice reduced pulmonary injury that was restored by adoptive transfer of 106 purified iNKT cells. Reconstituted injury was reversed by ATL146e unless the adoptively transferred iNKT cells were pretreated with the A2AR alkylating antagonist, FSPTP (5-amino-7-[2-(4-fluorosulfonyl)phenylethyl]-2-(2-furyl)-pryazolo[4,3-ϵ]-1,2,4-triazolo[1,5-c]pyrimidine), which completely prevented pro-tection. In NY1DD mice exposed to hypoxia-reoxygenation, treatment with ATL146e at the start of reoxygenation prevented further lung injury. Together, these data indicate that activation of induced A2ARs on iNKT and NK cells in SCD mice is sufficient to improve baseline pulmonary function and prevent hypoxia-reoxygenation–induced exacerbation of pulmonary injury. A2A agonists have promise for treating diseases associated with iNKT or NK cell activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Lysosomal Glycosphingolipid Recognition by NKT Cells
Zhou, D., Mattner, J., Cantu, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.-P., Yamashita, T., et al. (2004) · Science · doi:10.1126/science.1103440 · Cited by 956
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298
Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039438 · Cited by 263
A 2A -Adenosine Receptor Reserve for Coronary Vasodilation
Shryock, J. C., Snowdy, S., Baraldi, P. G., Cacciari, B., Spalluto, G., Monopoli, A., Ongini, E., Baker, S. P., & Belardinelli, L. (1998) · Circulation · doi:10.1161/01.cir.98.7.711 · Cited by 199
Research works printed but not linked: 45
- Wallace, 2009, NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines., Blood, 114, 667, 10.1182/blood-2009-02-205492 · DOI · Paper page
- Belcher, 2003, Transgenic sickle mice have vascular inflammation., Blood, 101, 3953, 10.1182/blood-2002-10-3313 · DOI · Paper page
- Kaul, 2000, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice., J Clin Invest, 106, 411, 10.1172/JCI9225 · DOI · Paper page
- Osarogiagbon, 2000, Reperfusion injury pathophysiology in sickle transgenic mice., Blood, 96, 314, 10.1182/blood.V96.1.314 · DOI · Paper page
- Dias-Da-Motta, 1996, The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia., Br J Haematol, 93, 333, 10.1046/j.1365-2141.1996.4951036.x · DOI
- Hebbel, 1982, Spontaneous oxygen radical generation by sickle erythrocytes., J Clin Invest, 70, 1253, 10.1172/JCI110724 · DOI · Paper page
- Turhan, 2002, Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm., Proc Natl Acad Sci U S A, 99, 3047, 10.1073/pnas.052522799 · DOI · Paper page
- Gray, 1991, Patterns of mortality in sickle cell disease in the United Kingdom., J Clin Pathol, 44, 459, 10.1136/jcp.44.6.459 · DOI · Paper page
- Minter, 2001, Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research., Am J Respir Crit Care Med, 164, 2016, 10.1164/ajrccm.164.11.2104101 · DOI
- Fabry, 1992, High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia., Proc Natl Acad Sci U S A, 89, 12155, 10.1073/pnas.89.24.12155 · DOI · Paper page
- Fabry, 1992, High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences., Proc Natl Acad Sci U S A, 89, 12150, 10.1073/pnas.89.24.12150 · DOI · Paper page
- Hofstra, 1996, Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst., Blood, 87, 4440, 10.1182/blood.V87.10.4440.bloodjournal87104440 · DOI · Paper page
- Platt, 2000, Sickle cell anemia as an inflammatory disease., J Clin Invest, 106, 337, 10.1172/JCI10726 · DOI · Paper page
- Bonneau, 2006, Effect of adenosine A2A receptor activation in murine models of respiratory disorders., Am J Physiol Lung Cell Mol Physiol, 290, L1036, 10.1152/ajplung.00422.2005 · DOI
- Fozard, 2002, Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat., Eur J Pharmacol, 438, 183, 10.1016/S0014-2999(02)01305-5 · DOI
- Nadeem, 2007, Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice., Am J Physiol Lung Cell Mol Physiol, 292, L1335, 10.1152/ajplung.00416.2006 · DOI
- Reutershan, 2007, Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury., J Immunol, 179, 1254, 10.4049/jimmunol.179.2.1254 · DOI · Paper page
- Harada, 2000, Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation., J Pharmacol Exp Ther, 294, 1034, 10.1016/S0022-3565(24)39168-2 · DOI
- Jordan, 1997, Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence., J Pharmacol Exp Ther, 280, 301, 10.1016/S0022-3565(24)36369-4 · DOI · Paper page
- Okusa, 2000, A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion., Am J Physiol Renal Physiol, 279, F809, 10.1152/ajprenal.2000.279.5.F809 · DOI · Paper page
- Ross, 1999, Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation., J Heart Lung Transplant, 18, 994, 10.1016/S1053-2498(99)00066-2 · DOI
- Thiel, 2003, The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases., Microbes Infect, 5, 515, 10.1016/S1286-4579(03)00068-6 · DOI
- Gessi, 2000, A(2A) adenosine receptors in human peripheral blood cells., Br J Pharmacol, 129, 2, 10.1038/sj.bjp.0703045 · DOI
- Lukashev, 2004, Targeting hypoxia–A(2A) adenosine receptor-mediated mechanisms of tissue protection., Drug Discov Today, 9, 403, 10.1016/S1359-6446(04)03044-2 · DOI
- Lappas, 2006, Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation., J Exp Med, 203, 2639, 10.1084/jem.20061097 · DOI · Paper page
- Li, 2007, NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury., J Immunol, 178, 5899, 10.4049/jimmunol.178.9.5899 · DOI · Paper page
- Wang, 2001, Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice., Infect Immun, 69, 5294, 10.1128/IAI.69.9.5294-5304.2001 · DOI
- Day, 2003, Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells., J Clin Invest, 112, 883, 10.1172/JCI15483 · DOI · Paper page
- Day, 2004, Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction., Am J Physiol Gastrointest Liver Physiol, 286, G285, 10.1152/ajpgi.00348.2003 · DOI · Paper page
- Yang, 2006, Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes., Circulation, 114, 2056, 10.1161/CIRCULATIONAHA.106.649244 · DOI · Paper page
- Dalton, 1988, Measurement of urinary para-aminohippuric acid in glycosuric diabetics., Kidney Int, 34, 117, 10.1038/ki.1988.153 · doi:10.1038/ki.1988.153
- Moser, 1989, Turnover of adenosine in plasma of human and dog blood., Am J Physiol, 256, C799, 10.1152/ajpcell.1989.256.4.C799 · DOI · Paper page
- Tofovic, 2009, Adenosine deaminase-adenosine pathway in hemolysis-associated pulmonary hypertension., Med Hypotheses, 72, 713, 10.1016/j.mehy.2008.12.043 · DOI
- Zhang, 2009, Detrimental role of excess adenosine-mediated 2,3-diphosphoglycerate induction in erythrocyte sickling and novel mechanism-based therapies., Blood, 114, 373
- Holtzclaw, 2004, Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice., Am J Respir Crit Care Med, 169, 687, 10.1164/rccm.200302-224OC · DOI · Paper page
- De Castro, 2008, Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes., Am J Hematol, 83, 19, 10.1002/ajh.21058 · DOI · Paper page
- Haque, 2002, Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases., Hum Pathol, 33, 1037, 10.1053/hupa.2002.128059 · DOI · Paper page
- Gumperz, 2000, Murine CD1d-restricted T cell recognition of cellular lipids., Immunity, 12, 211, 10.1016/S1074-7613(00)80174-0 · DOI · Paper page
- Porubsky, 2007, Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency., Proc Natl Acad Sci U S A, 104, 5977, 10.1073/pnas.0611139104 · DOI · Paper page
- Christiansen, 2008, Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation., PLoS Biol, 6, e172, 10.1371/journal.pbio.0060172 · DOI · Paper page
- Nagarajan, 2007, Invariant NKT cells amplify the innate immune response to lipopolysaccharide., J Immunol, 178, 2706, 10.4049/jimmunol.178.5.2706 · DOI · Paper page
- Weiner, 2003, Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease., JAMA, 289, 1136, 10.1001/jama.289.9.1136 · DOI · Paper page
- Atz, 1997, Inhaled nitric oxide in sickle cell disease with acute chest syndrome., Anesthesiology, 87, 988, 10.1097/00000542-199710000-00037 · DOI · Paper page
- Sullivan, 1999, Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent., Crit Care Med, 27, 2563, 10.1097/00003246-199911000-00039 · DOI
- Bunn, 2010, Pulmonary hypertension and nitric oxide depletion in sickle cell disease., Blood, 116, 687, 10.1182/blood-2010-02-268193 · DOI · Paper page
Cited by
Ischemia and reperfusion—from mechanism to translation
Eltzschig, H. K., & Eckle, T. (2011) · Nature Medicine · doi:10.1038/nm.2507 · Cited by 3,382
The ectonucleotidases CD 39 and CD 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Purinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787
Self-citation
Metadata
- Authors
- Wallace, K. L., & Linden, J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2010-12-02
- Volume
- 116
- Issue
- 23
- Pages
- 5010-5020
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2013297684
- Cited by
- 152
- References
- 8
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. https://app.cochat.ai/papers/10.1182/blood-2010-06-290643
- The paper
- Wallace, K. L., & Linden, J. (2010). Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood. https://doi.org/10.1182/blood-2010-06-290643
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.